By Product
Currency:CNY
2025/FY
Stock NameRevenueRatio
Antitumor class710.57M39.94%
Anti-infective class399.47M22.45%
慢性病类395.28M22.22%
Digestive class218.93M12.31%
Other business43.93M2.47%
Other classes10.84M0.61%
View all
By Industry
Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry1.74B97.53%
Other business43.93M2.47%
By Country/Region
Currency:CNY
2025/FY
Stock NameRevenueRatio
East China region729.91M41.03%
Central China274.45M15.43%
South China211.62M11.90%
North China181.29M10.19%
Southwest area174.29M9.80%
Northeast area105.78M5.95%
Northwest region57.77M3.25%
Other business43.93M2.47%
View all
